FSPGX
Price
$44.06
Change
+$0.40 (+0.92%)
Updated
Sep 4 closing price
Net Assets
39.83B
RGEBX
Price
$82.44
Change
+$0.19 (+0.23%)
Updated
Sep 5 closing price
Net Assets
331.65B
Interact to see
Advertisement

FSPGX vs RGEBX

Header iconFSPGX vs RGEBX Comparison
Open Charts FSPGX vs RGEBXBanner chart's image
Fidelity Large Cap Growth Idx
Price$44.06
Change+$0.40 (+0.92%)
VolumeN/A
Net Assets39.83B
American Funds Growth Fund of Amer R2E
Price$82.44
Change+$0.19 (+0.23%)
VolumeN/A
Net Assets331.65B
FSPGX vs RGEBX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
FSPGX vs. RGEBX commentary
Sep 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FSPGX is a StrongBuy and RGEBX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RGEBX has more cash in the bank: 332B vs. FSPGX (39.8B). FSPGX pays higher dividends than RGEBX: FSPGX (0.33) vs RGEBX (0.00). FSPGX was incepted earlier than RGEBX: FSPGX (9 years) vs RGEBX (11 years). RGEBX (1.09) is less costly to investors than FSPGX (0.04). RGEBX is a more actively managed with annual turnover of: 25.00 vs. FSPGX (9.00). FSPGX has a lower initial minimum investment than RGEBX: FSPGX (0) vs RGEBX (250). FSPGX annual gain was more profitable for investors over the last year : 27.85 vs. RGEBX (17.59). FSPGX return over 5 years is better than : 109.00 vs. RGEBX (38.71).
FSPGXRGEBXFSPGX / RGEBX
Total Expense Ratio0.041.093%
Annual Report Gross Expense Ratio0.041.093%
Fund Existence9 years11 years-
Gain YTD12.48415.39881%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets39.8B332B12%
Annual Yield % from dividends0.330.00-
Returns for 1 year27.8517.59158%
Returns for 3 years100.4957.61174%
Returns for 5 years109.0038.71282%
Returns for 10 yearsN/A91.44-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ARTV3.610.50
+16.08%
Artiva Biotherapeutics Inc
DNLI15.430.64
+4.33%
Denali Therapeutics
DOCS69.340.82
+1.20%
Doximity
SNDA25.80-0.03
-0.12%
Sonida Senior Living
CETX0.89N/A
-0.12%
Cemtrex In